Obstetrics & gynaecology

Researchers find antidepressant bupropion crosses placenta

(HealthDay)—In pregnant women taking the antidepressant bupropion, the drug and its active metabolites cross the placenta to the fetal circulation, according to a study published in the October issue of the American Journal ...

Obstetrics & gynaecology

Could assisted reproduction reduce birth defects for older women?

Babies born to women aged 40 and over from assisted reproduction have fewer birth defects compared with those from women who conceive naturally at the same age, according to new research from the University of Adelaide.

Obstetrics & gynaecology

Delayed pushing linked to longer second stage of labor

(HealthDay)—For nulliparous women, delayed pushing is associated with longer second stage duration and increased odds of cesarean delivery and postpartum hemorrhage, according to a study published in the November issue ...

Obstetrics & gynaecology

Ovarian preservation doesn't impact prognosis in cervical CA

(HealthDay)—For women with early-stage cervical adenocarcinoma, ovarian preservation does not impact survival, according to a study published in the October issue of the American Journal of Obstetrics & Gynecology.

Obstetrics & gynaecology

Hospitalizations in pregnancy, delivery stable for HIV-infected

(HealthDay)—From 2004 to 2011 there was no increase in the number of hospitalizations during pregnancy and delivery for HIV-infected women, according to a study published in the October issue of the American Journal of ...

Obstetrics & gynaecology

Misoprostol doesn't cut risk of postpartum hemorrhage

(HealthDay)—For women in the third stage of labor, misoprostol administered with routine oxytocin does not reduce the rate of postpartum hemorrhage, according to a study published online Sept. 5 in Obstetrics & Gynecology.

Obstetrics & gynaecology

Thirty-day readmission rate 2.8 percent after hysterectomy

(HealthDay)—For patients undergoing hysterectomy for benign indications, the 30-day readmission rate is 2.8 percent, with most readmissions occurring within 15 days, according to a study published in the October issue of ...

Obstetrics & gynaecology

Levonorgestrel IUD potentially cost-effective in obese women

(HealthDay)—For obese women, the levonorgestrel intrauterine device (IUD) could be cost-effective for preventing endometrial cancer deaths, according to a study published in the October issue of Obstetrics & Gynecology.

Obstetrics & gynaecology

ACOG addresses thrombocytopenia in pregnancy

(HealthDay)—Thrombocytopenia is common in pregnancy and can have causes that are serious medical disorders, with potential for maternal and fetal morbidity, according to a Practice Bulletin published in the September issue ...

Obstetrics & gynaecology

Success, safety up for ART with elective single embryo transfer

(HealthDay)—An updated Committee Opinion urges providers of assisted reproductive technology (ART) to do everything possible to reduce the likelihood of a multifetal pregnancy. The report is published in the September issue ...

page 3 from 40